The current status, attitudes, and practices concerning maternal pertussis vaccination in obstetric delivery facilities in Kanagawa Prefecture, Japan: a questionnaire survey

Hiiragi, Kazuya; Obata, Soichiro; Miyagi, Etsuko; Aoki, Shigeru

doi:10.1080/21645515.2021.1958609

Cited by 2 publications

(3 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In a questionnaire survey performed in Kanagawa, Japan, from June to July 2020 across 125 delivery service facilities (excluding midwifery clinics) of which 72 provided valid responses, none of the facilities offered pertussis vaccine to pregnant women 46 . The possibility of severe pertussis in newborns and infants was recognized by 40/72 (55.6%) facilities, whereas 23/72 (31.9%) recognized the preventive effects of maternal vaccination against pertussis 46 . All facilities responded that they would consider maternal vaccination against pertussis once it is recommended by Japanese guidelines 46 .…”

Section: Vaccine Hesitancy Among Pregnant Women and Factors Influenci...mentioning

confidence: 99%

“…The possibility of severe pertussis in newborns and infants was recognized by 40/72 (55.6%) facilities, whereas 23/72 (31.9%) recognized the preventive effects of maternal vaccination against pertussis 46 . All facilities responded that they would consider maternal vaccination against pertussis once it is recommended by Japanese guidelines 46 . In another questionnaire survey to investigate the effect of providing appropriate information on the acceptance of Tdap vaccination (if approved by the Japanese government or included in Japan's national immunization program) among pregnant Japanese women ( n = 481) and mothers ( n = 462) in Nara prefecture, Japan ( N = 943), 4.6% were aware that infantile pertussis could be prevented by maternal vaccination 47 .…”

Section: Vaccine Hesitancy Among Pregnant Women and Factors Influenci...mentioning

confidence: 99%

“… 46 All facilities responded that they would consider maternal vaccination against pertussis once it is recommended by Japanese guidelines. 46 In another questionnaire survey to investigate the effect of providing appropriate information on the acceptance of Tdap vaccination (if approved by the Japanese government or included in Japan's national immunization program) among pregnant Japanese women ( n = 481) and mothers ( n = 462) in Nara prefecture, Japan ( N = 943), 4.6% were aware that infantile pertussis could be prevented by maternal vaccination. 47 After reading the information provided, 877/943 (93.0%) participants thought that the maternal Tdap vaccine should be approved by the Japanese government and 873/943 (92.6%) thought that it should be included in the national immunization program; a significantly higher percentage of women were willing to take the Tdap vaccine with versus without government financial support (92.5% vs. 67.6%; p < 0.001).…”

Section: Vaccine Hesitancy Among Pregnant Women and Factors Influenci...mentioning

confidence: 99%

See 2 more Smart Citations

Maternal vaccination—current status, challenges, and opportunities

Kurasawa

2022

J of Obstet and Gynaecol

View full text Add to dashboard Cite

Aim Maternal vaccination is a promising strategy for protecting pregnant women and newborns against severe infections. This review aims to describe the current status and challenges associated with maternal vaccination against seasonal influenza, tetanus‐diphtheria‐pertussis (Tdap/DTaP), and novel coronavirus disease of 2019 (COVID‐19) in Japan and other countries, mainly the United States and the United Kingdom. Methods A literature search was conducted in PubMed and other public websites (e.g., Centers for Disease Control and Prevention) to obtain information on maternal vaccination. Results Inactivated vaccines are recommended for pregnant women by gynecologic societies in Japan, the United States, and the United Kingdom. Among pregnant Japanese women, the influenza and COVID‐19 (two doses) vaccine coverage rates were 27.0%–53.5% (six studies) and 73.6% (one study), respectively; there are no studies on maternal vaccination with DTaP. Concerns regarding vaccine safety are a major barrier to maternal vaccination across countries. Maternal vaccination is effective in preventing severe disease in pregnant women and protecting infants aged <6 months, is generally safe, and does not increase the risk of adverse maternal and fetal outcomes. Providing accurate information regarding vaccination through healthcare providers and the government and government funding for vaccines may help improve maternal vaccination rates in Japan. Conclusion Current coverage for maternal vaccination is still low globally mainly because of vaccine hesitancy among pregnant women. The government, drug‐regulatory authorities, and healthcare professionals must educate pregnant women about the effectiveness and safety of maternal vaccines and encourage vaccination when the benefits outweigh the risks.

show abstract

Section: Vaccine Hesitancy Among Pregnant Women and Factors Influenci...mentioning

confidence: 99%

Section: Vaccine Hesitancy Among Pregnant Women and Factors Influenci...mentioning

confidence: 99%

Section: Vaccine Hesitancy Among Pregnant Women and Factors Influenci...mentioning

confidence: 99%

See 1 more Smart Citation

Maternal vaccination—current status, challenges, and opportunities

Kurasawa

2022

J of Obstet and Gynaecol

View full text Add to dashboard Cite

show abstract

Understanding COVID-19 Vaccine Hesitancy among the General Population in Japan from Public Health Ethical Perspectives: Findings from a Narrative Review

Kuroda,

Ahmed,

Kuroda

et al. 2024

ABR

View full text Add to dashboard Cite

Japan has been reported as a country with high levels of vaccine hesitancy. However, a lack of comprehensive reviews studying factors for vaccine hesitancy for the COVID-19 vaccines in the Japanese context from the perspective of ethical controversy exists. Using a narrative review method, we reviewed factors associated with vaccine hesitancy to the COVID-19 vaccines and examined issues related to ethical controversy among the Japanese population. Factors associated with vaccine hesitancy include concerns about vaccine safety, suspicion of vaccine inefficacy, mistrust of the government, and low perceived threat. Factors associated with vaccine acceptance include environmental factors, factors related to Japanese cultural values, including collectivism and social norms, and positive attitudes toward information provided by authorities. Unique backgrounds in Japan are historical events such as the anti-HPV vaccine campaigns, the accessible medical system fostering high expectations of zero risk, and cultural factors of caring social norms influencing vaccine acceptance. Ethical controversies arise from preferences and practices at the individual or national level around individual rights versus public health benefits. Healthcare professionals and public health experts should continue dialoguing with the critical mass, practitioners, and policymakers, considering the ethical dilemmas surrounding individual rights and public health benefits. Insights obtained from this study indicate the need to develop tailored strategies to enhance vaccine acceptance while respecting individual autonomy within the Japanese context.

show abstract

The current status, attitudes, and practices concerning maternal pertussis vaccination in obstetric delivery facilities in Kanagawa Prefecture, Japan: a questionnaire survey

Cited by 2 publications

References 7 publications

Maternal vaccination—current status, challenges, and opportunities

Maternal vaccination—current status, challenges, and opportunities

Understanding COVID-19 Vaccine Hesitancy among the General Population in Japan from Public Health Ethical Perspectives: Findings from a Narrative Review

Contact Info

Product

Resources

About